OT: Just formed a new site: Giants in the making- 50 baggers.
No Pinks pennies or OTCs. Cannot think of a Bio/drug Company which had gone that far. PPHM previously TCLN went from $1-$14 after crawling from about .25cents, at a time pure patent registrations were commanding huge market caps.
I think it is unlikely any small drug Co will have a stand alone $1 billion plus drug. And my thoughts on the big "C" 350 (the entities looking for cancer cures) is that all are corrupted by having to find funding through peddling the idea they may find a super drug one size fits all (lottery concoctions). Yes there was Gleevec a DNA repair reverser, but that was for a non- solid tumor limited use easy pick-off ( I use that word "easy" glibbly tongue and cheek but short hand for its elemental usefullness to make my point). The cost to reclassify each cancer into its customized features (the arrayed differences found in each patients makeup) are way too unwieldly to presently address with current claffication tools. The cost to islolate a patients cancer on a dish is $500,000, add the same to test the best known weapons. The Company must be set up to state they are testing a drug with magnified market usefulness.
But to the point, if there is a drug Company one feels is ready to be considered a 50 bagger, kindly post once before this decade on that conceit uh I mean site.
